Innospec vs OLIN
IOSP and OLN side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IOSP and OLN compare
Innospec and OLIN are about the same size, with market caps of $1.9B and $2.0B.
Innospec grew revenue faster over the last twelve months (4.7% versus −0.73% for OLIN).
Both pay dividends: Innospec yields 2.3% and OLIN 4.5%.
Innospec scores higher on the StockData Score (14 against 10 for OLIN), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IOSP | OLN |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $2.0B |
| Share price | $78.29 | $17.89 |
| Change, 1 year | 4.3% | −7.5% |
| Change, 5 years | −10.4% | −70.3% |
| Beta (5Y) | 0.86 | 1.14 |
| Employees | 2,450 | 7,849 |
| StockData Score | ||
| Total score | 14 (better) | 10 |
| Valuation score | 4 (better) | 3 |
| Growth score | 1 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 6 (better) | 2 |
| Dividend score | 2 | 5 (better) |
| Valuation | ||
| P/S | 1.0× | 0.3× (better) |
| P/B | 1.4× | 1.2× (better) |
| EV/EBITDA | 8.3× (better) | 13.8× |
| P/FCF | – | 9.2× |
| FCF yield | – | 10.9% |
| Fair value | $110.48 | $37.61 |
| Margin of safety | 29.1% | 52.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.7% (better) | −0.73% |
| Revenue growth, 5Y average | 8.3% (better) | 3.3% |
| Net income growth (TTM) | – | −531% |
| EPS growth (TTM) | – | −535% |
| EPS growth, 5Y average | 32.1% | – |
| Profitability | ||
| Gross margin | 27.7% (better) | 6.7% |
| Operating margin | 8.8% (better) | −1.9% |
| Net margin | – | −3.3% |
| FCF margin | – | 3.3% |
| Return on equity | – | −12.2% |
| Return on invested capital | 12.4% (better) | −2.2% |
| Financial health | ||
| Debt / equity | 0.00 | 1.75 (better) |
| Net debt / EBITDA | – | 7.99 |
| Interest coverage | – | −0.7× |
| Current ratio | 2.95 (better) | 1.45 |
| Altman Z-score | 5.05 (better) | 1.55 |
| Piotroski F-score | – | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.3% | 4.5% (better) |
| Years of dividend growth | 12 | – |
| Dividend growth, 5Y average | 10.5% | – |
| Buyback yield | 0.70% (better) | 0.50% |
| Shareholder yield | 3.0% | 5.0% (better) |
| Ownership | ||
| Held by institutions | 101% | 99.8% |
| Held by insiders | 1.6% | 0.44% |
| Insider net buying, 12 months | −$902K (better) | −$2.4M |
| Superinvestors holding | – | 2 |
| Short interest, % of float | 1.9% | 12.2% |
Go deeper
- IOSP stock overview
- IOSP income statement
- IOSP valuation and score
- OLN stock overview
- OLN income statement
- OLN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.